News

PoNS, or portable neuromodulation stimulator, is a noninvasive device that sends mild electrical pulses through your tongue, nerves, and brain. PoNS may help people with MS improve walking and ...
The PoNS Device is a non-invasive solution designed to improve walking in patients with gait deficit resulting from MS. This condition impacts mobility and quality of life, making advancements in ...
Helius Medical Technologies will present PoNS® study results for MS at the CMSC Annual Meeting, highlighting sustained gait improvement.
The PoNS Device, priced at an out-of-network negotiated rate of $19,161, is a non-invasive treatment used to aid patients with multiple sclerosis (MS) in improving walking ability. This latest ...
Aetna approves reimbursement for the PoNS Device, joining Anthem and United, enhancing access for MS patients.
- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem ...
Helius Medical Technologies (NASDAQ:HSDT) shares are trading higher Wednesday after the company announced an authorized claim for payment for the PoNS Device from Aetna Healthcare.
The PoNS device works by delivering electrical impulses through nerve fibers on the tongue, stimulating the flow of neural impulses to brain structures that control gait and balance.
-Aetna authorizes claim for PoNS Device at out-of-network negotiated price of $18,350, becoming the third payer to join Anthem and United in providing PoNS reimbursement- -Out of Network ...